These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2529493)

  • 1. [Interstitial pneumopathies: criteria of drug side-effects. Results of consensus meetings].
    Fournier M; Camus P; Benichou C; Danan G; Begaud B; Castot A; Lagier G; Brune J; Pariente R; Chrétien J
    Presse Med; 1989 Sep 2-9; 18(27):1333-6. PubMed ID: 2529493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
    Danan G; Bénichou C; Begaud B; Biour M; Couzigou P; Evreux JC; Lagier G; Berthelot P; Benhamou JP
    Gastroenterol Clin Biol; 1987; 11(8-9):581-5. PubMed ID: 3308618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].
    Solal-Céligny P; Benichou C; Boivin P; Castot A; Coulombel L; Danan G; Degos L; Evreux JC; Lagier G; Lavarenne J
    Nouv Rev Fr Hematol (1978); 1987; 29(4):265-70. PubMed ID: 3320952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced renal insufficiency. Results of consensus meetings].
    Vigeral P; Baumelou A; Bénichou C; Castot A; Danan G; Kreft-Jais C; Lagier G; Rothschild E; Druet P; Grünfeld JP
    Nephrologie; 1989; 10(3):157-61. PubMed ID: 2691914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adverse drug reaction reporting system as an integral part of a drug-usage evaluation program.
    Saltiel E; Shane R
    Top Hosp Pharm Manage; 1991 Jul; 11(2):51-8. PubMed ID: 10128635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updating the French method for the causality assessment of adverse drug reactions.
    Arimone Y; Bidault I; Dutertre JP; Gérardin M; Guy C; Haramburu F; Hillaire-Buys D; Meglio C; Penfornis C; Théophile H; Valnet-Rabier MB;
    Therapie; 2013; 68(2):69-76. PubMed ID: 23773347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced cutaneous photosensitivity. Results of a consensus meeting].
    Roujeau JC; Beani JC; Dubertret L; Guillaume JC; Jeanmougin M; Danan G; Lagier G; Benichou C
    Therapie; 1989; 44(3):223-7. PubMed ID: 2528839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardized assessment of adverse drug reactions: the method used in France. Special workshop--clinical.
    Begaud B
    Drug Inf J; 1984; 18(3-4):275-81. PubMed ID: 10268556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Will France ever have a radio-vigilance office?].
    Perrot JL; Beyens MN; Vallard A; Magné N; Cinotti E
    Bull Cancer; 2019 Dec; 106(12):1067-1069. PubMed ID: 31350014
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug-induced pneumopathies (excluding cytostatic drugs)].
    Akoun G; Milleron B; Mayaud C
    Ann Med Interne (Paris); 1989; 140(7):593-6. PubMed ID: 2610452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The French pharmacovigilance system: structure and missions].
    Welsch M; Alt M; Richard MH; Imbs JL
    Presse Med; 2000 Jan; 29(2):102-6. PubMed ID: 10682040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Organization and results of drug vigilance in France].
    Bégaud B; Chaslerie A; Haramburu F
    Rev Epidemiol Sante Publique; 1994; 42(5):416-23. PubMed ID: 7973001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causality assessment in pharmacovigilance: The French method and its successive updates.
    Miremont-Salamé G; Théophile H; Haramburu F; Bégaud B
    Therapie; 2016 Apr; 71(2):179-86. PubMed ID: 27080836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adverse effects of calcium channels blockers used as tocolytic treatment].
    Clouqueur E; Gautier S; Vaast P; Coulon C; Deruelle P; Subtil D; Debarge V
    J Gynecol Obstet Biol Reprod (Paris); 2015 Apr; 44(4):341-56. PubMed ID: 25726253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The detection of adverse reactions to therapeutic drugs.
    Finney DJ
    Stat Med; 1982; 1(2):153-61. PubMed ID: 7187090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [French system of drug surveillance].
    Imbs JL; Castot A; Begaud B; Larousse C; Blayac JP; Alexandre JM
    Bull Acad Natl Med; 1998; 182(7):1383-91; discussion 1392-3. PubMed ID: 9916332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-induced pancreatitis. A review of French spontaneous reports].
    Chebane L; Bagheri H; Hillaire-Buys D; Géniaux H; Yahioui N; Laroche ML; Cottin J; Spreux A; Mosquet B; Pecriaux C; Bellet F; Lambert A; Montastruc JL
    Rev Med Interne; 2015 Sep; 36(9):573-8. PubMed ID: 26045335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Financial analysis of hospitalizations for adverse effects of drugs. The economic role of the Regional Pharmacovigilance Center].
    Mignot G; Biaggi J; Lethurgez P; Chichmanian RM
    Therapie; 1990; 45(5):387-90. PubMed ID: 2260030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.